Condition: Thyroid Eye Disease · Graves Ophthalmopathy · Graves Disease · Sponsor: Walter Reed National Military Medical Center
This protocol studies the clinical outcome of patients with active thyroid disease with visually significant signs and symptoms of proptosis, pain, diplopiam lid/orbital edema, or lid/orbital erythema recommended for treatment with teprotumumab infusion (Tepezza®). Patients recommended for treatment will be evaluated by an oculoplastic surgeon (Dr. Eva Chou) and endocrinologist (Dr. Thanh Hoang).
This description comes directly from the study's public registry record.
THANH D HOANG, DO · 3012955165 · thanh.d.hoang.mil@health.mil
Iris Morris, PhD · 3013194599 · iris.e.morris3.civ@health.mil
Always discuss trial participation with your own doctor first.
| Walter Reed National Military Medical Center | Bethesda, Maryland, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06275373